The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2019

Filed:

Sep. 15, 2014
Applicant:

Ethicon, Inc., Somerville, NJ (US);

Inventors:

Kevin Weadock, Hillsborough, NJ (US);

Jeffrey Hammond, Bernardsville, NJ (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 17/34 (2006.01); A61M 25/01 (2006.01); A61N 5/10 (2006.01); A61K 31/7068 (2006.01); A61K 31/513 (2006.01); A61K 31/4375 (2006.01); A61K 31/282 (2006.01); A61K 38/38 (2006.01); A61K 33/24 (2019.01); A61K 31/704 (2006.01); A61K 31/337 (2006.01); A61N 5/02 (2006.01); A61N 1/20 (2006.01); A61N 5/00 (2006.01); A61M 25/09 (2006.01); A61B 1/04 (2006.01); A61B 1/06 (2006.01); A61N 1/05 (2006.01); A61M 25/06 (2006.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01); A61B 90/00 (2016.01); A61N 1/32 (2006.01); A61B 1/015 (2006.01); A61B 5/00 (2006.01); A61B 18/00 (2006.01); A61B 10/02 (2006.01); A61B 6/12 (2006.01); A61B 8/08 (2006.01); A61B 5/055 (2006.01);
U.S. Cl.
CPC ...
A61M 25/0169 (2013.01); A61B 1/04 (2013.01); A61B 1/06 (2013.01); A61B 17/3421 (2013.01); A61B 17/3468 (2013.01); A61B 90/39 (2016.02); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/4375 (2013.01); A61K 31/513 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01); A61K 33/24 (2013.01); A61K 38/385 (2013.01); A61M 25/06 (2013.01); A61M 25/09 (2013.01); A61M 31/00 (2013.01); A61M 31/002 (2013.01); A61M 31/007 (2013.01); A61M 37/0092 (2013.01); A61N 1/05 (2013.01); A61N 1/20 (2013.01); A61N 5/00 (2013.01); A61N 5/02 (2013.01); A61N 5/1001 (2013.01); A61N 5/1027 (2013.01); A61B 1/015 (2013.01); A61B 5/055 (2013.01); A61B 5/4839 (2013.01); A61B 6/12 (2013.01); A61B 8/085 (2013.01); A61B 10/0233 (2013.01); A61B 90/361 (2016.02); A61B 2017/3445 (2013.01); A61B 2018/00005 (2013.01); A61B 2018/00273 (2013.01); A61B 2018/00601 (2013.01); A61B 2018/00613 (2013.01); A61B 2018/00982 (2013.01); A61B 2018/00994 (2013.01); A61B 2090/3908 (2016.02); A61B 2090/3987 (2016.02); A61M 2025/0166 (2013.01); A61M 2025/09125 (2013.01); A61M 2025/09141 (2013.01); A61M 2025/09166 (2013.01); A61M 2025/09175 (2013.01); A61N 1/327 (2013.01);
Abstract

Novel systems for and methods of delivering therapeutic agents to target tissues are disclosed. The method of delivering a therapeutic agent to a target tissue involves identifying a target tissue via an imaging modality and then using a guidewire capable of anchoring in tissue to advance a cannula to the target tissue. The guidewire and novel cannula configurations enable rapid and repeated treatments of the target tissue without the need for subsequent imaging. The cannula is coupled to a source of ultrasound, radiation, radiofrequency energy, or chemotherapeutic agents which can then be delivered to from the cannula the target tissue. The system and method can be used to treat tumors that are small or surgically inoperable. In addition, the system can be used to treat lymphatic tissue that may contain metastases from the tumors.


Find Patent Forward Citations

Loading…